Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    TED11746
Show Display Options
Rank Status Study
1 Completed A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Condition: Neoplasm Malignant
Interventions: Drug: Iniparib (SAR240550-BSI-201);   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Placlitaxel;   Drug: Pegylated liposomal doxorubicin

Study has passed its completion date and status has not been verified in more than two years.